Healthy Skepticism Library item: 6456

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Sherman B.
Indications for growth hormone.
Lancet 1994 Oct 15; 344:(8929):1095

Abstract:

Genentech was not charged although a Genentech executive was charged. Genentech does not promote height screening as a promotional tactic for growth hormone. The company’s promotional practices have been strictly within Food and Drug Administration guidelines.

Keywords:
Child Federal Government Government Regulation Growth Hormone/deficiency Growth Hormone/therapeutic use* Humans Professional Misconduct* Recombinant Proteins/therapeutic use Technology, High-Cost United States *letter to the editor/United States/Genentech/growth hormone/ criminal charges/ drug company sponsored research/marketing strategies/industry perspective/health and healthcare/INFLUENCE OF PROMOTION: HEALTH AND HEALTH CARE/PROMOTIONAL TECHNIQUES: FALSE SCREENING PROGRAMS